Comparing the efficacy and safety ofCrocus sativusL. with memantine in patients with moderate to severe Alzheimer's disease: a double-blind randomized clinical trial

Abe, 2000, Effects of saffron extract and its constituent crocin on learning behaviour and long-term potentiation, Phytother Res, 14, 149, 10.1002/(SICI)1099-1573(200005)14:3<149::AID-PTR665>3.0.CO;2-5

Ahn, 2011, Crocetin inhibits beta-amyloid fibrillization and stabilizes beta-amyloid oligomers, Biochem Biophys Res Commun, 414, 79, 10.1016/j.bbrc.2011.09.025

Akhondzadeh, 2006, Herbal medicine in the treatment of Alzheimer's disease, Am J Alzheimers Dis Other Demen, 21, 113, 10.1177/153331750602100211

Akhondzadeh Basti, 2007, Comparison of petal of Crocus sativus L. and fluoxetine in the treatment of depressed outpatients: a pilot double-blind randomized trial, Prog Neuropsychopharmacol Biol Psychiatry, 31, 439, 10.1016/j.pnpbp.2006.11.010

Akhondzadeh, 2004, Comparison of Crocus sativus L. and imipramine in the treatment of mild to moderate depression: a pilot double-blind randomized trial [ISRCTN45683816], Complement Altern Med, 4, 12, 10.1186/1472-6882-4-12

Akhondzadeh, 2005, Crocus sativus L. in the treatment of mild to moderate depression: a double-blind, randomized and placebo-controlled trial, Phytother Res, 19, 148, 10.1002/ptr.1647

Akhondzadeh, 2010a, Saffron in the treatment of patients with mild to moderate Alzheimer's disease: a 16-week, randomized and placebo-controlled trial, J Clin Pharm Ther, 35, 581, 10.1111/j.1365-2710.2009.01133.x

Akhondzadeh, 2010b, A 22-week, multicenter, randomized, double-blind controlled trial of Crocus sativus in the treatment of mild-to-moderate Alzheimer's disease, Psychopharmacology (Berl), 207, 637, 10.1007/s00213-009-1706-1

Auer, 1994, The neglected half of Alzheimer disease: cognitive and functional concomitants of severe dementia, J Am Geriatr Soc, 42, 1266, 10.1111/j.1532-5415.1994.tb06509.x

Ballard, 2008, Neuropsychiatric symptoms in dementia: importance and treatment considerations, Int Rev Psychiatry, 20, 396, 10.1080/09540260802099968

Berger, 2011, Saffron extract and trans-crocetin inhibit glutamatergic synaptic transmission in rat cortical brain slices, Neuroscience, 180, 238, 10.1016/j.neuroscience.2011.02.037

Choe, 2008, The Severe Cognitive Impairment Rating Scale - an instrument for the assessment of cognition in moderate to severe dementia patients, Dement Geriatr Cogn Disord, 25, 321, 10.1159/000119124

Chopra, 2011, Neurobiological aspects of Alzheimer's disease, Expert Opin Ther Targets, 15, 535, 10.1517/14728222.2011.557363

Cummings, 2002, Alzheimer disease, JAMA, 287, 2335, 10.1001/jama.287.18.2335

Folstein, 1983, The Mini-Mental State Examination, Arch Gen Psychiatry, 40, 812, 10.1001/archpsyc.1983.01790060110016

Forchetti, 2005, Treating patients with moderate to severe Alzheimer's disease: implications of recent pharmacologic studies, Prim Care Companion J Clin Psychiatry, 7, 155, 10.4088/PCC.v07n0403

Geromichalos, 2012, Saffron as a source of novel acetylcholinesterase inhibitors: molecular docking and in vitro enzymatic studies, J Agric Food Chem, 60, 6131, 10.1021/jf300589c

Ghadrdoost, 2011, Protective effects of saffron extract and its active constituent crocin against oxidative stress and spatial learning and memory deficits induced by chronic stress in rats, Eur J Pharmacol, 667, 222, 10.1016/j.ejphar.2011.05.012

Grossberg, 2013, The safety, tolerability, and efficacy of once-daily memantine (28 mg): a multinational, randomized, double-blind, placebo-controlled trial in patients with moderate-to-severe Alzheimer's disease taking cholinesterase inhibitors, CNS Drugs, 27, 469, 10.1007/s40263-013-0077-7

Herrmann, 2008, Diagnosis and treatment of dementia: 6. Management of severe Alzheimer disease, CMAJ, 179, 1279, 10.1503/cmaj.070804

Hosseinzadeh, 2008, Effect of safranal on extracellular hippocampal levels of glutamate and aspartate during kainic Acid treatment in anesthetized rats, Planta Med, 74, 1441, 10.1055/s-2008-1081335

Hsiung, 2008, Pharmacological treatment in moderate-to-severe Alzheimer's disease, Expert Opin Pharmacother, 9, 2575, 10.1517/14656566.9.15.2575

Johnson, 2011, Neuropsychiatric profiles in dementia, Alzheimer Dis Assoc Disord, 25, 326, 10.1097/WAD.0b013e31820d89b6

Kamalipour, 2011, Cardiovascular effects of saffron: an evidence-based review, J Tehran Heart Cent, 6, 59

Kennedy, 2011, Herbal extracts and phytochemicals: plant secondary metabolites and the enhancement of human brain function, Adv Nutr, 2, 32, 10.3945/an.110.000117

Kumar, 2006, Potential medicinal plants for CNS disorders: an overview, Phytother Res, 20, 1023, 10.1002/ptr.1970

Lee, 2003, Depression in Alzheimer's disease: heterogeneity and related issues, Biol Psychiatry, 54, 353, 10.1016/S0006-3223(03)00543-2

Mckhann, 1984, Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease, Neurology, 34, 939, 10.1212/WNL.34.7.939

Melnyk, 2010, Chemical and biological properties of the world's most expensive spice: saffron, Food Res Int, 43, 1981, 10.1016/j.foodres.2010.07.033

Modabbernia, 2013, Saffron, passionflower, valerian and sage for mental health, Psychiatr Clin North Am, 36, 85, 10.1016/j.psc.2012.12.007

Modaghegh, 2008, Safety evaluation of saffron (Crocus sativus) tablets in healthy volunteers, Phytomedicine, 15, 1032, 10.1016/j.phymed.2008.06.003

Montoro, 2012, Radical scavenging activity and LC-MS metabolic profiling of petals, stamens, and flowers of Crocus sativus L, J Food Sci, 77, C893, 10.1111/j.1750-3841.2012.02803.x

Moreira, 2005, Oxidative stress mechanisms and potential therapeutics in Alzheimer disease, J Neural Transm, 112, 921, 10.1007/s00702-004-0242-8

Moshiri, 2006, Crocus sativus L. (petal) in the treatment of mild-to-moderate depression: a double-blind, randomized and placebo-controlled trial, Phytomedicine, 13, 607, 10.1016/j.phymed.2006.08.006

Noorbala, 2005, Hydro-alcoholic extract of Crocus sativus L. versus fluoxetine in the treatment of mild to moderate depression: a double-blind, randomized pilot trial, J Ethnopharmacol, 97, 281, 10.1016/j.jep.2004.11.004

Ochiai, 2007, Protective effects of carotenoids from saffron on neuronal injury in vitro and in vivo, Biochim Biophys Acta, 1770, 578, 10.1016/j.bbagen.2006.11.012

Ohno, 2012, Oral administration of crocetin prevents inner retinal damage induced by N-methyl-d-aspartate in mice, Eur J Pharmacol, 690, 84, 10.1016/j.ejphar.2012.06.035

Papandreou, 2006, Inhibitory activity on amyloid-beta aggregation and antioxidant properties of Crocus sativus stigmas extract and its crocin constituents, J Agric Food Chem, 54, 8762, 10.1021/jf061932a

Papandreou, 2011, Memory enhancing effects of saffron in aged mice are correlated with antioxidant protection, Behav Brain Res, 219, 197, 10.1016/j.bbr.2011.01.007

Pitsikas, 2006, Crocus sativus L. extracts antagonize memory impairments in different behavioural tasks in the rat, Behav Brain Res, 173, 112, 10.1016/j.bbr.2006.06.005

Pitsikas, 2007, Effects of the active constituents of Crocus sativus L., crocins on recognition and spatial rats' memory, Behav Brain Res, 183, 141, 10.1016/j.bbr.2007.06.001

Prasansuklab, 2013, Amyloidosis in Alzheimer's disease: the toxicity of amyloid beta (A beta), mechanisms of its accumulation and implications of medicinal plants for therapy, Evid Based Complement Alternat Med, 2013, 413808, 10.1155/2013/413808

Revett, 2013, Glutamate system, amyloid ss peptides and tau protein: functional interrelationships and relevance to Alzheimer disease pathology, J Psychiatry Neurosci, 38, 6, 10.1503/jpn.110190

Riederer, 2006, From benefit to damage. Glutamate and advanced glycation end products in Alzheimer brain, J Neural Transm, 113, 1671, 10.1007/s00702-006-0591-6

Schmidt, 2007, Saffron in phytotherapy: pharmacology and clinical uses, Wien Med Wochenschr, 157, 315, 10.1007/s10354-007-0428-4

Schneider, 2011, Lack of evidence for the efficacy of memantine in mild Alzheimer disease, Arch Neurol, 68, 991, 10.1001/archneurol.2011.69

Sclan, 1992, Functional assessment staging (FAST) in Alzheimer's disease: reliability, validity, and ordinality, Int Psychogeriatr, 4, 55, 10.1017/S1041610292001157

Serrano-Diaz, 2012, Increasing the applications of Crocus sativus flowers as natural antioxidants, J Food Sci, 77, C1162, 10.1111/j.1750-3841.2012.02926.x

Srivastava, 2010, Crocus sativus L.: a comprehensive review, Pharmacogn Rev, 4, 200, 10.4103/0973-7847.70919

Ulbricht, 2011, An evidence-based systematic review of saffron (Crocus sativus) by the Natural Standard Research Collaboration, J Diet Suppl, 8, 58, 10.3109/19390211.2011.547666

Zhang, 1994, Effects of Crocus sativus L. on the ethanol-induced impairment of passive avoidance performances in mice, Biol Pharm Bull, 17, 217, 10.1248/bpb.17.217

Zhao, 2008, Healthcare costs and utilization for Medicare beneficiaries with Alzheimer's, BMC Health Serv Res, 8, 108, 10.1186/1472-6963-8-108